{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:26:21Z","timestamp":1794489981660,"version":"4.9.1"},"publisher-location":"Cham","reference-count":182,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319096131","type":"print"},{"value":"9783319096148","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-09614-8_12","type":"book-chapter","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T08:08:16Z","timestamp":1417421296000},"page":"197-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Alcohol and HCV: Implications for Liver Cancer"],"prefix":"10.1007","author":[{"given":"Gyongyi","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banishree","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence N.","family":"Bukong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"12_CR1","first-page":"266","volume":"21","author":"GL Davis","year":"2008","unstructured":"Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, Berger BD, O\u2019connor JK, Goldstein RM (2008) Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) 21:266\u2013280","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","volume":"127","author":"TR Morgan","year":"2004","unstructured":"Morgan TR, Mandayam S, Jamal MM (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127:S87\u2013S96","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"12_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","volume":"15","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Yoon SK, Lencioni R (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15(Suppl 4):14\u201322","journal-title":"Oncologist"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygeno.2013.04.001","volume":"102","author":"ML Tornesello","year":"2013","unstructured":"Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM (2013) Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 102:74\u201383","journal-title":"Genomics"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/sj.onc.1209562","volume":"25","author":"M Levrero","year":"2006","unstructured":"Levrero M (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834\u20133847","journal-title":"Oncogene"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","volume":"19","author":"R Bartenschlager","year":"2011","unstructured":"Bartenschlager R, Penin F, Lohmann V, Andre P (2011) Assembly of infectious hepatitis C virus particles. Trends Microbiol 19:95\u2013103","journal-title":"Trends Microbiol"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307\u2013328","journal-title":"Hepatology"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1756283X10378925","volume":"4","author":"TH Frazier","year":"2011","unstructured":"Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ (2011) Treatment of alcoholic liver disease. Therap Adv Gastroenterol 4:63\u201381","journal-title":"Therap Adv Gastroenterol"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000336913","volume":"30","author":"G Szabo","year":"2012","unstructured":"Szabo G, Lippai D (2012) Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 30:243\u2013248","journal-title":"Dig Dis"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"518674","DOI":"10.1155\/2010\/518674","volume":"2010","author":"K Machida","year":"2010","unstructured":"Machida K (2010) TLRs, alcohol, HCV, and tumorigenesis. Gastroenterol Res Pract 2010:518674","journal-title":"Gastroenterol Res Pract"},{"issue":"Suppl 1","key":"12_CR11","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1440-1746.2007.05292.x","volume":"23","author":"K Koike","year":"2008","unstructured":"Koike K, Tsutsumi T, Miyoshi H, Shinzawa S, Shintani Y, Fujie H, Yotsuyanagi H, Moriya K (2008) Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis. J Gastroenterol Hepatol 23(Suppl 1):S87\u2013S91","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR12","first-page":"498","volume":"91","author":"AS Rosman","year":"1996","unstructured":"Rosman AS, Waraich A, Galvin K, Casiano J, Paronetto F, Lieber CS (1996) Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol 91:498\u2013505","journal-title":"Am J Gastroenterol"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"95S","DOI":"10.1016\/S0002-9343(99)00393-9","volume":"107","author":"ER Schiff","year":"1999","unstructured":"Schiff ER (1999) The alcoholic patient with hepatitis C virus infection. Am J Med 107:95S\u201399S","journal-title":"Am J Med"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1111\/j.1530-0277.2000.tb00024.x","volume":"24","author":"T Tanaka","year":"2000","unstructured":"Tanaka T, Yabusako T, Yamashita T, Kondo K, Nishiguchi S, Kuroki T, Monna T (2000) Contribution of hepatitis C virus to the progression of alcoholic liver disease. Alcohol Clin Exp Res 24:112S\u2013116S","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1530-0277.1999.tb04679.x","volume":"23","author":"A Regev","year":"1999","unstructured":"Regev A, Jeffers LJ (1999) Hepatitis C and alcohol. Alcohol Clin Exp Res 23:1543\u20131551","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/gut.49.6.750","volume":"49","author":"CP Day","year":"2001","unstructured":"Day CP (2001) Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis. Gut 49:750\u2013751","journal-title":"Gut"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","volume":"282","author":"AU Neumann","year":"1998","unstructured":"Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103\u2013107","journal-title":"Science"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/gut.51.1.132","volume":"51","author":"F Stickel","year":"2002","unstructured":"Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51:132\u2013139","journal-title":"Gut"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1111\/j.1530-0277.2001.tb02418.x","volume":"25","author":"N Enomoto","year":"2001","unstructured":"Enomoto N, Ikejima K, Yamashina S, Hirose M, Shimizu H, Kitamura T, Takei Y, Sato And N, Thurman RG (2001) Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res 25:51S\u201354S","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bpg.2003.10.005","volume":"18","author":"G Garcia-Tsao","year":"2004","unstructured":"Garcia-Tsao G, Wiest R (2004) Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 18:353\u2013372","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","volume":"48","author":"AJ Wigg","year":"2001","unstructured":"Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206\u2013211","journal-title":"Gut"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","volume":"42","author":"V Purohit","year":"2008","unstructured":"Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR (2008) Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42:349\u2013361","journal-title":"Alcohol"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","volume":"16","author":"G Szabo","year":"2010","unstructured":"Szabo G, Bala S (2010) Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 16:1321\u20131329","journal-title":"World J Gastroenterol"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"pii: 710381","DOI":"10.1155\/2010\/710381","volume":"2010","author":"J Petrasek","year":"2010","unstructured":"Petrasek J, Mandrekar P, Szabo G (2010) Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract 2010:pii: 710381","journal-title":"Gastroenterol Res Pract"},{"key":"12_CR25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1530-0277.2006.00083.x","volume":"30","author":"G Szabo","year":"2006","unstructured":"Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S (2006) Hepatitis C infection and alcohol use: a dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res 30:709\u2013719","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer U, Maini MK, Knolle PA (2012) Living in the liver: hepatic infections. Nat Rev Immunol 12:201\u2013213","journal-title":"Nat Rev Immunol"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.3253","volume":"19","author":"SM Horner","year":"2013","unstructured":"Horner SM, Gale M Jr (2013) Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 19:879\u2013888","journal-title":"Nat Med"},{"key":"12_CR28","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1128\/JVI.00996-08","volume":"83","author":"M Heydtmann","year":"2009","unstructured":"Heydtmann M (2009) Macrophages in hepatitis B and hepatitis C virus infections. J Virol 83:2796\u20132802","journal-title":"J Virol"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/eji.201142360","volume":"42","author":"BS Liu","year":"2012","unstructured":"Liu BS, Janssen HL, Boonstra A (2012) Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12. Eur J Immunol 42:2431\u20132440","journal-title":"Eur J Immunol"},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","volume":"177","author":"A Dolganiuc","year":"2006","unstructured":"Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G (2006) Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 177:6758\u20136768","journal-title":"J Immunol"},{"key":"12_CR31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/CVI.00141-07","volume":"14","author":"Z Fan","year":"2007","unstructured":"Fan Z, Huang XL, Kalinski P, Young S, Rinaldo CR Jr (2007) Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 14:1127\u20131137","journal-title":"Clin Vaccine Immunol"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2249.2007.03367.x","volume":"148","author":"AJ MacDonald","year":"2007","unstructured":"MacDonald AJ, Semper AE, Libri NA, Rosenberg WM (2007) Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells. Clin Exp Immunol 148:494\u2013500","journal-title":"Clin Exp Immunol"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1086\/425425","volume":"190","author":"T Kanto","year":"2004","unstructured":"Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190:1919\u20131926","journal-title":"J Infect Dis"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1189\/jlb.0112050","volume":"92","author":"S Bala","year":"2012","unstructured":"Bala S, Tang A, Catalano D, Petrasek J, Taha O, Kodys K, Szabo G (2012) Induction of Bcl-3 by acute binge alcohol results in toll-like receptor 4\/LPS tolerance. J Leukoc Biol 92:611\u2013620","journal-title":"J Leukoc Biol"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2172-12-55","volume":"12","author":"M Pang","year":"2011","unstructured":"Pang M, Bala S, Kodys K, Catalano D, Szabo G (2011) Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes. BMC Immunol 12:55","journal-title":"BMC Immunol"},{"key":"12_CR36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1530-0277.2008.00726.x","volume":"32","author":"O Norkina","year":"2008","unstructured":"Norkina O, Dolganiuc A, Catalano D, Kodys K, Mandrekar P, Syed A, Efros M, Szabo G (2008) Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. Alcohol Clin Exp Res 32:1565\u20131573","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2010.05.008","volume":"112","author":"L Ye","year":"2010","unstructured":"Ye L, Wang S, Wang X, Zhou Y, Li J, Persidsky Y, Ho W (2010) Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes. Drug Alcohol Depend 112:107\u2013116","journal-title":"Drug Alcohol Depend"},{"key":"12_CR38","doi-asserted-by":"crossref","first-page":"e1003316","DOI":"10.1371\/journal.ppat.1003316","volume":"9","author":"AE Stone","year":"2013","unstructured":"Stone AE, Giugliano S, Schnell G, Cheng L, Leahy KF, Golden-Mason L, Gale M Jr, Rosen HR (2013) Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLoS Pathog 9:e1003316","journal-title":"PLoS Pathog"},{"key":"12_CR39","first-page":"548390","volume":"2010","author":"HM Liu","year":"2010","unstructured":"Liu HM, Gale M (2010) Hepatitis C virus evasion from RIG-I-dependent hepatic innate immunity. Gastroenterol Res Pract 2010:548390","journal-title":"Gastroenterol Res Pract"},{"issue":"414\u2013425","key":"12_CR40","first-page":"e7","volume":"144","author":"S Zhang","year":"2013","unstructured":"Zhang S, Kodys K, Li K, Szabo G (2013) Human type 2 myeloid dendritic cells produce interferon-lambda and amplify interferon-alpha in response to hepatitis C virus infection. Gastroenterology 144(414\u2013425):e7","journal-title":"Gastroenterology"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.26017","volume":"57","author":"S Nitta","year":"2013","unstructured":"Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-Kitazume A, Kiyohashi K, Murakawa M, Nishimura-Sakurai Y, Azuma S, Tasaka-Fujita M, Asahina Y, Yoneyama M, Fujita T, Watanabe M (2013) Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology 57:46\u201358","journal-title":"Hepatology"},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","volume":"102","author":"K Li","year":"2005","unstructured":"Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM (2005) Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102:2992\u20132997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR43","first-page":"321","volume":"369","author":"JM Pawlotsky","year":"2013","unstructured":"Pawlotsky JM (2013) Treatment of chronic hepatitis C: current and future. Curr Top Microbiol Immunol 369:321\u2013342","journal-title":"Curr Top Microbiol Immunol"},{"key":"12_CR44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1517\/13543784.2013.806482","volume":"22","author":"N Shah","year":"2013","unstructured":"Shah N, Pierce T, Kowdley KV (2013) Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. Expert Opin Investig Drugs 22:1107\u20131121","journal-title":"Expert Opin Investig Drugs"},{"key":"12_CR45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/0003-4819-158-2-201301150-00576","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Hartung D, Rahman B, Wasson N, Cottrell EB, Fu R (2013) Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med 158:114\u2013123","journal-title":"Ann Intern Med"},{"key":"12_CR46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MCG.0b013e3180381584","volume":"41","author":"AK Singal","year":"2007","unstructured":"Singal AK, Anand BS (2007) Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol 41:761\u2013772","journal-title":"J Clin Gastroenterol"},{"key":"12_CR47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0029-1214374","volume":"29","author":"L Siu","year":"2009","unstructured":"Siu L, Foont J, Wands JR (2009) Hepatitis C virus and alcohol. Semin Liver Dis 29:188\u2013199","journal-title":"Semin Liver Dis"},{"key":"12_CR48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/alcalc\/agp091","volume":"45","author":"PA Shuper","year":"2010","unstructured":"Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J (2010) Causal considerations on alcohol and HIV\/AIDS\u2014a systematic review. Alcohol Alcohol 45:159\u2013166","journal-title":"Alcohol Alcohol"},{"key":"12_CR49","first-page":"97","volume":"33","author":"PE Molina","year":"2010","unstructured":"Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S (2010) Focus on: alcohol and the immune system. Alcohol Res Health 33:97\u2013108","journal-title":"Alcohol Res Health"},{"key":"12_CR50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.alcohol.2007.07.001","volume":"41","author":"TR Jerrells","year":"2007","unstructured":"Jerrells TR, Pavlik JA, Devasure J, Vidlak D, Costello A, Strachota JM, Wyatt TA (2007) Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice. Alcohol 41:357\u2013369","journal-title":"Alcohol"},{"key":"12_CR51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drugalcdep.2009.11.011","volume":"108","author":"Y Le Strat","year":"2010","unstructured":"Le Strat Y, Grant BF, Ramoz N, Gorwood P (2010) A new definition of early age at onset in alcohol dependence. Drug Alcohol Depend 108:43\u201348","journal-title":"Drug Alcohol Depend"},{"key":"12_CR52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1743-422X-2-89","volume":"2","author":"CR Plumlee","year":"2005","unstructured":"Plumlee CR, Lazaro CA, Fausto N, Polyak SJ (2005) Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol J 2:89","journal-title":"Virol J"},{"key":"12_CR53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1743-422X-9-126","volume":"9","author":"M Imran","year":"2012","unstructured":"Imran M, Waheed Y, Manzoor S, Bilal M, Ashraf W, Ali M, Ashraf M (2012) Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virol J 9:126","journal-title":"Virol J"},{"key":"12_CR54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/655812","volume":"202","author":"H Chung","year":"2010","unstructured":"Chung H, Watanabe T, Kudo M, Chiba T (2010) Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2. J Infect Dis 202:853\u2013861","journal-title":"J Infect Dis"},{"key":"12_CR55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.0207128","volume":"82","author":"S Chang","year":"2007","unstructured":"Chang S, Dolganiuc A, Szabo G (2007) Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol 82:479\u2013487","journal-title":"J Leukoc Biol"},{"key":"12_CR56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","volume":"127","author":"A Dolganiuc","year":"2004","unstructured":"Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513\u20131524","journal-title":"Gastroenterology"},{"key":"12_CR57","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","volume":"87","author":"S Shrivastava","year":"2013","unstructured":"Shrivastava S, Mukherjee A, Ray R, Ray RB (2013) Hepatitis C virus induces interleukin-1beta (IL-1beta)\/IL-18 in circulatory and resident liver macrophages. J Virol 87:12284\u201312290","journal-title":"J Virol"},{"key":"12_CR58","doi-asserted-by":"crossref","first-page":"e1003330","DOI":"10.1371\/journal.ppat.1003330","volume":"9","author":"AA Negash","year":"2013","unstructured":"Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M Jr (2013) IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 9:e1003330","journal-title":"PLoS Pathog"},{"key":"12_CR59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10620-010-1395-y","volume":"56","author":"N Hosomura","year":"2011","unstructured":"Hosomura N, Kono H, Tsuchiya M, Ishii K, Ogiku M, Matsuda M, Fujii H (2011) HCV-related proteins activate Kupffer cells isolated from human liver tissues. Dig Dis Sci 56:1057\u20131064","journal-title":"Dig Dis Sci"},{"key":"12_CR60","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2007.08.003","volume":"133","author":"A Dolganiuc","year":"2007","unstructured":"Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G (2007) Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133:1627\u20131636","journal-title":"Gastroenterology"},{"key":"12_CR61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1479-5876-10-151","volume":"10","author":"S Bala","year":"2012","unstructured":"Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D, Szabo G (2012) Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 10:151","journal-title":"J Transl Med"},{"key":"12_CR62","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","volume":"72","author":"C Coulouarn","year":"2012","unstructured":"Coulouarn C, Corlu A, Glaise D, Guenon I, Thorgeirsson SS, Clement B (2012) Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res 72:2533\u20132542","journal-title":"Cancer Res"},{"key":"12_CR63","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/1078-0432.CCR-12-0928","volume":"19","author":"J Brownell","year":"2013","unstructured":"Brownell J, Polyak SJ (2013) Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer. Clin Cancer Res 19:1347\u20131352","journal-title":"Clin Cancer Res"},{"key":"12_CR64","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v16.i11.1304","volume":"16","author":"HJ Wang","year":"2010","unstructured":"Wang HJ, Zakhari S, Jung MK (2010) Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gastroenterol 16:1304\u20131313","journal-title":"World J Gastroenterol"},{"key":"12_CR65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.23790","volume":"52","author":"G Szabo","year":"2010","unstructured":"Szabo G (2010) The 40th anniversary of the National Institute on Alcoholism and Alcohol Abuse: the impact on liver disease. Hepatology 52:10\u201312","journal-title":"Hepatology"},{"key":"12_CR66","first-page":"87","volume":"33","author":"G Szabo","year":"2010","unstructured":"Szabo G, Mandrekar P (2010) Focus on: alcohol and the liver. Alcohol Res Health 33:87\u201396","journal-title":"Alcohol Res Health"},{"key":"12_CR67","first-page":"1509","volume":"35","author":"S Inokuchi","year":"2011","unstructured":"Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E (2011) Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 35:1509\u20131518","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/alcalc\/37.1.81","volume":"37","author":"C Schafer","year":"2002","unstructured":"Schafer C, Parlesak A, Schutt C, Bode JC, Bode C (2002) Concentrations of lipopolysaccharide-binding protein, bactericidal\/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 37:81\u201386","journal-title":"Alcohol Alcohol"},{"key":"12_CR69","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1038\/onc.2008.277","volume":"27","author":"GE Blair","year":"2008","unstructured":"Blair GE, Cook GP (2008) Cancer and the immune system: an overview. Oncogene 27:5868","journal-title":"Oncogene"},{"key":"12_CR70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","volume":"16","author":"TL Whiteside","year":"2006","unstructured":"Whiteside TL (2006) Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 16:3\u201315","journal-title":"Semin Cancer Biol"},{"key":"12_CR71","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.alc.0000179364.32003.9f","volume":"29","author":"T Zhang","year":"2005","unstructured":"Zhang T, Guo CJ, Douglas SD, Metzger DS, O\u2019brien CP, Li Y, Wang YJ, Wang X, Ho WZ (2005) Alcohol suppresses IL-2-induced CC chemokine production by natural killer cells. Alcohol Clin Exp Res 29:1559\u20131567","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nm0496-457","volume":"2","author":"S Ben-Eliyahu","year":"1996","unstructured":"Ben-Eliyahu S, Page GG, Yirmiya R, Taylor AN (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2:457\u2013460","journal-title":"Nat Med"},{"key":"12_CR73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.0707472","volume":"83","author":"H Zhang","year":"2008","unstructured":"Zhang H, Meadows GG (2008) Chronic alcohol consumption perturbs the balance between thymus-derived and bone marrow-derived natural killer cells in the spleen. J Leukoc Biol 83:41\u201347","journal-title":"J Leukoc Biol"},{"key":"12_CR74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.173.1.42","volume":"173","author":"NI Boyadjieva","year":"2004","unstructured":"Boyadjieva NI, Chaturvedi K, Poplawski MM, Sarkar DK (2004) Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function. J Immunol 173:42\u201349","journal-title":"J Immunol"},{"key":"12_CR75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","volume":"134","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Park O, Gao B (2008) Abrogation of the antifibrotic effects of natural killer cells\/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134:248\u2013258","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"12_CR76","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1111\/j.1440-1746.2007.05274.x","volume":"23","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Gao B (2008) Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol 23(Suppl 1):S112\u2013S118","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR77","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1530-0277.2008.00852.x","volume":"33","author":"H Zhang","year":"2009","unstructured":"Zhang H, Meadows GG (2009) Exogenous IL-15 in combination with IL-15R alpha rescues natural killer cells from apoptosis induced by chronic alcohol consumption. Alcohol Clin Exp Res 33:419\u2013427","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","volume":"11","author":"HG Ljunggren","year":"1990","unstructured":"Ljunggren HG, Karre K (1990) In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition. Immunol Today 11:237\u2013244","journal-title":"Immunol Today"},{"key":"12_CR79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2010.04169.x","volume":"161","author":"RJ Harrison","year":"2010","unstructured":"Harrison RJ, Ettorre A, Little AM, Khakoo SI (2010) Association of NKG2A with treatment for chronic hepatitis C virus infection. Clin Exp Immunol 161:306\u2013314","journal-title":"Clin Exp Immunol"},{"key":"12_CR80","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2011.06.069","volume":"141","author":"G Ahlenstiel","year":"2011","unstructured":"Ahlenstiel G, Edlich B, Hogdal LJ, Rotman Y, Noureddin M, Feld JJ, Holz LE, Titerence RH, Liang TJ, Rehermann B (2011) Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 141:1231\u20131239e1-2","journal-title":"Gastroenterology"},{"key":"12_CR81","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2010.01.006","volume":"138","author":"B Amadei","year":"2010","unstructured":"Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P, Missale G, Ferrari C, Khakoo SI (2010) Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138:1536\u20131545","journal-title":"Gastroenterology"},{"key":"12_CR82","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2013.04.022","volume":"59","author":"S Zhang","year":"2013","unstructured":"Zhang S, Saha B, Kodys K, Szabo G (2013) IFN-gamma production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. J Hepatol 59:442\u2013449","journal-title":"J Hepatol"},{"key":"12_CR83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2010.02.008","volume":"393","author":"O Dessouki","year":"2010","unstructured":"Dessouki O, Kamiya Y, Nagahama H, Tanaka M, Suzu S, Sasaki Y, Okada S (2010) Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. Biochem Biophys Res Commun 393:331\u2013337","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.24628","volume":"55","author":"B Edlich","year":"2012","unstructured":"Edlich B, Ahlenstiel G, Zabaleta Azpiroz A, Stoltzfus J, Noureddin M, Serti E, Feld JJ, Liang TJ, Rotman Y, Rehermann B (2012) Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 55:39\u201348","journal-title":"Hepatology"},{"key":"12_CR85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2008.03.521","volume":"128","author":"VD Gonzalez","year":"2008","unstructured":"Gonzalez VD, Falconer K, Michaelsson J, Moll M, Reichard O, Alaeus A, Sandberg JK (2008) Expansion of CD56- NK cells in chronic HCV\/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol 128:46\u201356","journal-title":"Clin Immunol"},{"key":"12_CR86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/17474124.1.1.173","volume":"1","author":"B Gao","year":"2007","unstructured":"Gao B, Radaeva S, Jeong WI (2007) Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev Gastroenterol Hepatol 1:173\u2013180","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"12_CR87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O (2009) Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 86:513\u2013528","journal-title":"J Leukoc Biol"},{"key":"12_CR88","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.gastro.2007.11.061","volume":"134","author":"GE Arteel","year":"2008","unstructured":"Arteel GE (2008) Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells. Gastroenterology 134:351\u2013353","journal-title":"Gastroenterology"},{"key":"12_CR89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.imbio.2005.05.018","volume":"210","author":"G Szabo","year":"2005","unstructured":"Szabo G, Dolganiuc A (2005) Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210:237\u2013247","journal-title":"Immunobiology"},{"key":"12_CR90","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.alcohol.2004.07.003","volume":"33","author":"G Szabo","year":"2004","unstructured":"Szabo G, Dolganiuc A, Mandrekar P, White B (2004) Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection. Alcohol 33:241\u2013249","journal-title":"Alcohol"},{"key":"12_CR91","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1530-0277.2003.tb04431.x","volume":"27","author":"A Dolganiuc","year":"2003","unstructured":"Dolganiuc A, Kodys K, Kopasz A, Marshall C, Mandrekar P, Szabo G (2003) Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction. Alcohol Clin Exp Res 27:1023\u20131031","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR92","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.170.11.5615","volume":"170","author":"A Dolganiuc","year":"2003","unstructured":"Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L Jr, Mandrekar P, Zapp M, Szabo G (2003) Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 170:5615\u20135624","journal-title":"J Immunol"},{"key":"12_CR93","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.173.5.3398","volume":"173","author":"P Mandrekar","year":"2004","unstructured":"Mandrekar P, Catalano D, Dolganiuc A, Kodys K, Szabo G (2004) Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production. J Immunol 173:3398\u20133407","journal-title":"J Immunol"},{"key":"12_CR94","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00409-07","volume":"81","author":"L Golden-Mason","year":"2007","unstructured":"Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81:9249\u20139258","journal-title":"J Virol"},{"key":"12_CR95","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/QAD.0b013e32836285e4","volume":"27","author":"B Saha","year":"2013","unstructured":"Saha B, Choudhary MC, Sarin SK (2013) Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus\/HIV coinfection as compared to hepatitis C virus or HIV monoinfection. AIDS 27:2191\u20132200","journal-title":"AIDS"},{"key":"12_CR96","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2007.12.014","volume":"48","author":"S Urbani","year":"2008","unstructured":"Urbani S, Amadei B, Tola D, Pedrazzi G, Sacchelli L, Cavallo MC, Orlandini A, Missale G, Ferrari C (2008) Restoration of HCV-specific T cell functions by PD-1\/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 48:548\u2013558","journal-title":"J Hepatol"},{"key":"12_CR97","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120:4546\u20134557","journal-title":"J Clin Invest"},{"key":"12_CR98","doi-asserted-by":"crossref","first-page":"e4319","DOI":"10.1371\/journal.pone.0004319","volume":"4","author":"F Gondois-Rey","year":"2009","unstructured":"Gondois-Rey F, Dental C, Halfon P, Baumert TF, Olive D, Hirsch I (2009) Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS One 4:e4319","journal-title":"PLoS One"},{"key":"12_CR99","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1189\/jlb.1210680","volume":"89","author":"BS Liu","year":"2011","unstructured":"Liu BS, Groothuismink ZM, Janssen HL, Boonstra A (2011) Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections. J Leukoc Biol 89:981\u2013988","journal-title":"J Leukoc Biol"},{"key":"12_CR100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jhep.2009.03.014","volume":"51","author":"M Wegert","year":"2009","unstructured":"Wegert M, La Monica N, Tripodi M, Adler G, Dikopoulos N (2009) Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice. J Hepatol 51:271\u2013278","journal-title":"J Hepatol"},{"key":"12_CR101","doi-asserted-by":"crossref","first-page":"37481","DOI":"10.1074\/jbc.M506412200","volume":"280","author":"M Korenaga","year":"2005","unstructured":"Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Weinman SA (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280:37481\u201337488","journal-title":"J Biol Chem"},{"key":"12_CR102","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1097\/01.mcg.0000155517.02468.46","volume":"39","author":"M Korenaga","year":"2005","unstructured":"Korenaga M, Okuda M, Otani K, Wang T, Li Y, Weinman SA (2005) Mitochondrial dysfunction in hepatitis C. J Clin Gastroenterol 39:S162\u2013S166","journal-title":"J Clin Gastroenterol"},{"key":"12_CR103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2119\/molmed.2009.00165","volume":"16","author":"VR Mas","year":"2010","unstructured":"Mas VR, Fassnacht R, Archer KJ, Maluf D (2010) Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 16:287\u2013297","journal-title":"Mol Med"},{"key":"12_CR104","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065\u20131067","journal-title":"Nat Med"},{"key":"12_CR105","first-page":"4365","volume":"61","author":"K Moriya","year":"2001","unstructured":"Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365\u20134370","journal-title":"Cancer Res"},{"key":"12_CR106","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/gast.2002.30983","volume":"122","author":"M Okuda","year":"2002","unstructured":"Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366\u2013375","journal-title":"Gastroenterology"},{"key":"12_CR107","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2008.12.026","volume":"50","author":"N Dionisio","year":"2009","unstructured":"Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, Salido GM, Gonzalez-Gallego J (2009) Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol 50:872\u2013882","journal-title":"J Hepatol"},{"key":"12_CR108","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2004.10.045","volume":"128","author":"K Otani","year":"2005","unstructured":"Otani K, Korenaga M, Beard MR, Li K, Qian T, Showalter LA, Singh AK, Wang T, Weinman SA (2005) Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 128:96\u2013107","journal-title":"Gastroenterology"},{"key":"12_CR109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1530-0277.2006.00003.x","volume":"30","author":"A Dolganiuc","year":"2006","unstructured":"Dolganiuc A, Bakis G, Kodys K, Mandrekar P, Szabo G (2006) Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol Clin Exp Res 30:76\u201385","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2009.11.006","volume":"52","author":"AG Testro","year":"2010","unstructured":"Testro AG, Gow PJ, Angus PW, Wongseelashote S, Skinner N, Markovska V, Visvanathan K (2010) Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis. J Hepatol 52:199\u2013205","journal-title":"J Hepatol"},{"key":"12_CR111","doi-asserted-by":"crossref","first-page":"140S","DOI":"10.1097\/01.alc.0000189287.83544.33","volume":"29","author":"G Szabo","year":"2005","unstructured":"Szabo G, Velayudham A, Romics L Jr, Mandrekar P (2005) Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29:140S\u2013145S","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR112","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1073\/pnas.0807390106","volume":"106","author":"K Machida","year":"2009","unstructured":"Machida K, Tsukamoto H, Mkrtchyan H, Duan L, Dynnyk A, Liu HM, Asahina K, Govindarajan S, Ray R, Ou JH, Seki E, Deshaies R, Miyake K, Lai MM (2009) Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci U S A 106:1548\u20131553","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR113","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920","journal-title":"Science"},{"key":"12_CR114","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hep.25745","volume":"56","author":"J Shan","year":"2012","unstructured":"Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q, Ma L, Liu J, Xu S, Yan X, Bie P, Cui Y, Bian XW, Qian C (2012) Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology 56:1004\u20131014","journal-title":"Hepatology"},{"key":"12_CR115","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.biocel.2013.02.017","volume":"45","author":"C Sun","year":"2013","unstructured":"Sun C, Sun L, Jiang K, Gao DM, Kang XN, Wang C, Zhang S, Huang S, Qin X, Li Y, Liu YK (2013) NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL\/SMAD3 signaling pathway. Int J Biochem Cell Biol 45:1099\u20131108","journal-title":"Int J Biochem Cell Biol"},{"key":"12_CR116","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00535-005-1738-1","volume":"41","author":"Y Hara","year":"2006","unstructured":"Hara Y, Hino K, Okuda M, Furutani T, Hidaka I, Yamaguchi Y, Korenaga M, Li K, Weinman SA, Lemon SM, Okita K (2006) Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J Gastroenterol 41:257\u2013268","journal-title":"J Gastroenterol"},{"key":"12_CR117","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1073\/pnas.171311298","volume":"98","author":"G Gong","year":"2001","unstructured":"Gong G, Waris G, Tanveer R, Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A 98:9599\u20139604","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR118","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/v5030954","volume":"5","author":"C Brault","year":"2013","unstructured":"Brault C, Levy PL, Bartosch B (2013) Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 5:954\u2013980","journal-title":"Viruses"},{"key":"12_CR119","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/acer.12005","volume":"37","author":"W Hou","year":"2013","unstructured":"Hou W, Bukong TN, Kodys K, Szabo G (2013) Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells. Alcohol Clin Exp Res 37:599\u2013608","journal-title":"Alcohol Clin Exp Res"},{"key":"12_CR120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/jbc.M109.045740","volume":"285","author":"S Seronello","year":"2010","unstructured":"Seronello S, Ito C, Wakita T, Choi J (2010) Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH\/NAD+. J Biol Chem 285:845\u2013854","journal-title":"J Biol Chem"},{"key":"12_CR121","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<737::AID-IJC8>3.0.CO;2-S","volume":"71","author":"HS Lee","year":"1997","unstructured":"Lee HS, Yoon JH, Kamimura S, Iwata K, Watanabe H, Kim CY (1997) Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer 71:737\u2013740","journal-title":"Int J Cancer"},{"key":"12_CR122","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1272\/jnms.69.243","volume":"69","author":"Y Hirose","year":"2002","unstructured":"Hirose Y, Naito Z, Kato S, Onda M, Sugisaki Y (2002) Immunohistochemical study of CYP2E1 in hepatocellular carcinoma carcinogenesis: examination with newly prepared anti-human CYP2E1 antibody. J Nippon Med Sch 69:243\u2013251","journal-title":"J Nippon Med Sch"},{"key":"12_CR123","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s13277-012-0326-2","volume":"33","author":"C Liu","year":"2012","unstructured":"Liu C, Wang H, Pan C, Shen J, Liang Y (2012) CYP2E1 PstI\/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls. Tumour Biol 33:979\u2013984","journal-title":"Tumour Biol"},{"key":"12_CR124","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drudis.2007.10.007","volume":"13","author":"DB Solit","year":"2008","unstructured":"Solit DB, Chiosis G (2008) Development and application of Hsp90 inhibitors. Drug Discov Today 13:38\u201343","journal-title":"Drug Discov Today"},{"key":"12_CR125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","volume":"10","author":"J Trepel","year":"2010","unstructured":"Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537\u2013549","journal-title":"Nat Rev Cancer"},{"key":"12_CR126","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1016\/S0021-9258(19)38314-0","volume":"265","author":"MJ Schlesinger","year":"1990","unstructured":"Schlesinger MJ (1990) Heat shock proteins. J Biol Chem 265:12111\u201312114","journal-title":"J Biol Chem"},{"key":"12_CR127","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1139\/o05-158","volume":"83","author":"R Zhao","year":"2005","unstructured":"Zhao R, Houry WA (2005) Hsp90: a chaperone for protein folding and gene regulation. Biochem Cell Biol 83:703\u2013710","journal-title":"Biochem Cell Biol"},{"key":"12_CR128","doi-asserted-by":"crossref","first-page":"412985","DOI":"10.1155\/2010\/412985","volume":"2010","author":"JE Bohonowych","year":"2010","unstructured":"Bohonowych JE, Gopal U, Isaacs JS (2010) Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls. J Oncol 2010:412985","journal-title":"J Oncol"},{"key":"12_CR129","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1126\/science.1073051","volume":"296","author":"BC Freeman","year":"2002","unstructured":"Freeman BC, Yamamoto KR (2002) Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296:2232\u20132235","journal-title":"Science"},{"key":"12_CR130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1073\/pnas.0809669106","volume":"106","author":"M Tariq","year":"2009","unstructured":"Tariq M, Nussbaumer U, Chen Y, Beisel C, Paro R (2009) Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proc Natl Acad Sci U S A 106:1157\u20131162","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR131","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1535-7163.1021.3.8","volume":"3","author":"R Bagatell","year":"2004","unstructured":"Bagatell R, Whitesell L (2004) Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 3:1021\u20131030","journal-title":"Mol Cancer Ther"},{"key":"12_CR132","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ncb1131","volume":"6","author":"BK Eustace","year":"2004","unstructured":"Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C, Lain B, Torella C, Henning SW, Beste G, Scroggins BT, Neckers L, Ilag LL, Jay DG (2004) Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6:507\u2013514","journal-title":"Nat Cell Biol"},{"key":"12_CR133","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030\u20133044","journal-title":"Int J Cancer"},{"key":"12_CR134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C De Martel","year":"2012","unstructured":"De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607\u2013615","journal-title":"Lancet Oncol"},{"key":"12_CR135","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","volume":"30","author":"DR McGivern","year":"2011","unstructured":"McGivern DR, Lemon SM (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30:1969\u20131983","journal-title":"Oncogene"},{"key":"12_CR136","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1189\/jlb.0407256","volume":"84","author":"P Mandrekar","year":"2008","unstructured":"Mandrekar P, Catalano D, Jeliazkova V, Kodys K (2008) Alcohol exposure regulates heat shock transcription factor binding and heat shock proteins 70 and 90 in monocytes and macrophages: implication for TNF-alpha regulation. J Leukoc Biol 84:1335\u20131345","journal-title":"J Leukoc Biol"},{"key":"12_CR137","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/hep.26010","volume":"57","author":"TN Bukong","year":"2013","unstructured":"Bukong TN, Hou W, Kodys K, Szabo G (2013) Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells. Hepatology 57:70\u201380","journal-title":"Hepatology"},{"key":"12_CR138","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/hep.24802","volume":"55","author":"A Ambade","year":"2012","unstructured":"Ambade A, Catalano D, Lim A, Mandrekar P (2012) Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology 55:1585\u20131595","journal-title":"Hepatology"},{"key":"12_CR139","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/ijms11041423","volume":"11","author":"Y Sun","year":"2010","unstructured":"Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L (2010) Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry. Int J Mol Sci 11:1423\u20131433","journal-title":"Int J Mol Sci"},{"key":"12_CR140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.22912","volume":"50","author":"M Breinig","year":"2009","unstructured":"Breinig M, Caldas-Lopes E, Goeppert B, Malz M, Rieker R, Bergmann F, Schirmacher P, Mayer M, Chiosis G, Kern MA (2009) Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma. Hepatology 50:102\u2013112","journal-title":"Hepatology"},{"key":"12_CR141","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.20962","volume":"42","author":"RM Pascale","year":"2005","unstructured":"Pascale RM, Simile MM, Calvisi DF, Frau M, Muroni MR, Seddaiu MA, Daino L, Muntoni MD, De Miglio MR, Thorgeirsson SS, Feo F (2005) Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology 42:1310\u20131319","journal-title":"Hepatology"},{"key":"12_CR142","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1128\/JVI.01035-09","volume":"83","author":"S Taguwa","year":"2009","unstructured":"Taguwa S, Kambara H, Omori H, Tani H, Abe T, Mori Y, Suzuki T, Yoshimori T, Moriishi K, Matsuura Y (2009) Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway. J Virol 83:10427\u201310436","journal-title":"J Virol"},{"key":"12_CR143","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2006.12.117","volume":"353","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M (2007) Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem Biophys Res Commun 353:882\u2013888","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR144","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1038\/sj.emboj.7601367","volume":"25","author":"T Okamoto","year":"2006","unstructured":"Okamoto T, Nishimura Y, Ichimura T, Suzuki K, Miyamura T, Suzuki T, Moriishi K, Matsuura Y (2006) Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J 25:5015\u20135025","journal-title":"EMBO J"},{"key":"12_CR145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.virusres.2011.10.003","volume":"163","author":"S Ujino","year":"2012","unstructured":"Ujino S, Nishitsuji H, Sugiyama R, Suzuki H, Hishiki T, Sugiyama K, Shimotohno K, Takaku H (2012) The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site. Virus Res 163:390\u2013395","journal-title":"Virus Res"},{"key":"12_CR146","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1074\/jbc.M806452200","volume":"284","author":"S Ujino","year":"2009","unstructured":"Ujino S, Yamaguchi S, Shimotohno K, Takaku H (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem 284:6841\u20136846","journal-title":"J Biol Chem"},{"key":"12_CR147","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev.ge.18.120184.003005","volume":"18","author":"HE Varmus","year":"1984","unstructured":"Varmus HE (1984) The molecular genetics of cellular oncogenes. Annu Rev Genet 18:553\u2013612","journal-title":"Annu Rev Genet"},{"key":"12_CR148","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1128\/JVI.02253-07","volume":"82","author":"T Okamoto","year":"2008","unstructured":"Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, Miyamura T, Yoshimori T, Moriishi K, Matsuura Y (2008) A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 82:3480\u20133489","journal-title":"J Virol"},{"key":"12_CR149","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","volume":"22","author":"S Takayama","year":"2003","unstructured":"Takayama S, Reed JC, Homma S (2003) Heat-shock proteins as regulators of apoptosis. Oncogene 22:9041\u20139047","journal-title":"Oncogene"},{"key":"12_CR150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1582-4934.2008.00273.x","volume":"12","author":"D Lanneau","year":"2008","unstructured":"Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M, Garrido C (2008) Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12:743\u2013761","journal-title":"J Cell Mol Med"},{"key":"12_CR151","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10495-010-0542-4","volume":"16","author":"L Bai","year":"2011","unstructured":"Bai L, Xu S, Chen W, Li Z, Wang X, Tang H, Lin Y (2011) Blocking Nf-kappaB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death. Apoptosis 16:45\u201354","journal-title":"Apoptosis"},{"key":"12_CR152","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1042\/CBI20110473","volume":"36","author":"AM Leng","year":"2012","unstructured":"Leng AM, Liu T, Yang J, Cui JF, Li XH, Zhu YN, Xiong T, Zhang G, Chen Y (2012) The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells. Cell Biol Int 36:893\u2013899","journal-title":"Cell Biol Int"},{"key":"12_CR153","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.22685","volume":"49","author":"SA Lang","year":"2009","unstructured":"Lang SA, Moser C, Fichnter-Feigl S, Schachtschneider P, Hellerbrand C, Schmitz V, Schlitt HJ, Geissler EK, Stoeltzing O (2009) Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice. Hepatology 49:523\u2013532","journal-title":"Hepatology"},{"key":"12_CR154","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jhep.2012.01.009","volume":"56","author":"A Lachenmayer","year":"2012","unstructured":"Lachenmayer A, Toffanin S, Cabellos L, Alsinet C, Hoshida Y, Villanueva A, Minguez B, Tsai HW, Ward SC, Thung S, Friedman SL, Llovet JM (2012) Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol 56:1343\u20131350","journal-title":"J Hepatol"},{"key":"12_CR155","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.510270635","volume":"27","author":"F Pessione","year":"1998","unstructured":"Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, Degott C, Valla D, Erlinger S, Rueff B (1998) Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 27:1717\u20131722","journal-title":"Hepatology"},{"key":"12_CR156","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2004-832942","volume":"24","author":"K Safdar","year":"2004","unstructured":"Safdar K, Schiff ER (2004) Alcohol and hepatitis C. Semin Liver Dis 24:305\u2013315","journal-title":"Semin Liver Dis"},{"key":"12_CR157","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/gut.2004.056697","volume":"54","author":"BS Anand","year":"2005","unstructured":"Anand BS, Thornby J (2005) Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 54:1468\u20131472","journal-title":"Gut"},{"key":"12_CR158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","volume":"1","author":"J Chang","year":"2004","unstructured":"Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM (2004) miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1:106\u2013113","journal-title":"RNA Biol"},{"key":"12_CR159","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12:735\u2013739","journal-title":"Curr Biol"},{"key":"12_CR160","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1042\/BST0361220","volume":"36","author":"CL Jopling","year":"2008","unstructured":"Jopling CL (2008) Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 36:1220\u20131223","journal-title":"Biochem Soc Trans"},{"key":"12_CR161","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chom.2008.05.013","volume":"4","author":"CL Jopling","year":"2008","unstructured":"Jopling CL, Schutz S, Sarnow P (2008) Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4:77\u201385","journal-title":"Cell Host Microbe"},{"key":"12_CR162","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"CL Jopling","year":"2005","unstructured":"Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577\u20131581","journal-title":"Science"},{"key":"12_CR163","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1073\/pnas.1012464108","volume":"108","author":"ES Machlin","year":"2011","unstructured":"Machlin ES, Sarnow P, Sagan SM (2011) Masking the 5\u2032 terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 108:3193\u20133198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR164","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","volume":"28","author":"C Coulouarn","year":"2009","unstructured":"Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28:3526\u20133536","journal-title":"Oncogene"},{"key":"12_CR165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcb.20982","volume":"99","author":"H Kutay","year":"2006","unstructured":"Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99:671\u2013678","journal-title":"J Cell Biochem"},{"key":"12_CR166","doi-asserted-by":"crossref","first-page":"498232","DOI":"10.1155\/2012\/498232","volume":"2012","author":"S Bala","year":"2012","unstructured":"Bala S, Szabo G (2012) MicroRNA signature in alcoholic liver disease. Int J Hepatol 2012:498232","journal-title":"Int J Hepatol"},{"key":"12_CR167","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","volume":"106","author":"K Wang","year":"2009","unstructured":"Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106:4402\u20134407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR168","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/bmm.12.107","volume":"7","author":"OF Laterza","year":"2013","unstructured":"Laterza OF, Scott MG, Garrett-Engele PW, Korenblat KM, Lockwood CM (2013) Circulating miR-122 as a potential biomarker of liver disease. Biomark Med 7:205\u2013210","journal-title":"Biomark Med"},{"key":"12_CR169","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvh.12001","volume":"20","author":"AJ Van Der Meer","year":"2013","unstructured":"Van Der Meer AJ, Farid WR, Sonneveld MJ, De Ruiter PE, Boonstra A, Van Vuuren AJ, Verheij J, Hansen BE, De Knegt RJ, Van Der Laan LJ, Janssen HL (2013) Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 20:158\u2013166","journal-title":"J Viral Hepat"},{"key":"12_CR170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","volume":"10","author":"G Szabo","year":"2013","unstructured":"Szabo G, Bala S (2013) MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 10:542\u2013552","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12_CR171","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","volume":"122","author":"WC Tsai","year":"2012","unstructured":"Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP (2012) MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122:2884\u20132897","journal-title":"J Clin Invest"},{"key":"12_CR172","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122:2871\u20132883","journal-title":"J Clin Invest"},{"key":"12_CR173","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","volume":"284","author":"S Bai","year":"2009","unstructured":"Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284:32015\u201332027","journal-title":"J Biol Chem"},{"key":"12_CR174","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198\u2013201","journal-title":"Science"},{"key":"12_CR175","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, Van Der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368:1685\u20131694","journal-title":"N Engl J Med"},{"key":"12_CR176","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","volume":"141","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141:1220\u20131230e1-3","journal-title":"Gastroenterology"},{"key":"12_CR177","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2174\/1381612024606983","volume":"8","author":"L Caradonna","year":"2002","unstructured":"Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, Manghisi OG, Caccavo D, Pellegrino NM, Amoroso A, Jirillo E, Amati L (2002) Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des 8:995\u20131005","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"12_CR178","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gutjnl-2012-302144","volume":"61","author":"C Welsch","year":"2012","unstructured":"Welsch C, Jesudian A, Zeuzem S, Jacobson I (2012) New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. Gut 61(Suppl 1):i36\u2013i46","journal-title":"Gut"},{"issue":"Suppl 1","key":"12_CR179","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","volume":"56","author":"C Sarrazin","year":"2012","unstructured":"Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM (2012) Antiviral strategies in hepatitis C virus infection. J Hepatol 56(Suppl 1):S88\u2013S100","journal-title":"J Hepatol"},{"key":"12_CR180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.31.10.951","volume":"31","author":"OM Klibanov","year":"2011","unstructured":"Klibanov OM, Williams SH, Smith LS, Olin JL, Vickery SB (2011) Telaprevir: a novel NS3\/4 protease inhibitor for the treatment of hepatitis C. Pharmacotherapy 31:951\u2013974","journal-title":"Pharmacotherapy"},{"key":"12_CR181","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/PHAR.1046","volume":"32","author":"OM Klibanov","year":"2012","unstructured":"Klibanov OM, Vickery SB, Olin JL, Smith LS, Williams SH (2012) Boceprevir: a novel NS3\/4 protease inhibitor for the treatment of hepatitis C. Pharmacotherapy 32:173\u2013190","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"12_CR182","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/liv.12423","volume":"34","author":"R Schinazi","year":"2014","unstructured":"Schinazi R, Halfon P, Marcellin P, Asselah T (2014) HCV direct-acting antiviral agents: the best interferon-free combinations. Liver Int 34(Suppl 1):69\u201378","journal-title":"Liver Int"}],"container-title":["Advances in Experimental Medicine and Biology","Biological Basis of Alcohol-Induced Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-09614-8_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T21:41:04Z","timestamp":1676410864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-09614-8_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"ISBN":["9783319096131","9783319096148"],"references-count":182,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-09614-8_12","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-09614-8","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,10]]},"assertion":[{"value":"10 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}